ATI
NYSEMaterialsLoading…
ATI Inc. Common Stock
Sector: Materials•United States•Market Cap: $19.5B
Related News
Latest stories connected to ATI
10/17More news →
- RS 75ATI (ATI) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research•15h ago•Original source
- RS 75
- RS 75ATI vs. CRS: Which Specialty Metals Stock Should You Invest in Now?Zacks Investment Research•5d ago•Original source
- RS 75Are Aerospace Stocks Lagging ATI INC (ATI) This Year?Zacks Investment Research•6d ago•Original source
- RS 75Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual MeetingGlobeNewsWire•Mar 20, 2026•Original source
- RS 75Can ATI Sustain Its Robust Free Cash Flow Momentum in 2026?Zacks Investment Research•Mar 18, 2026•Original source
- RS 75Why ATI (ATI) is a Top Growth Stock for the Long-TermZacks Investment Research•Mar 18, 2026•Original source
- RS 753 Reasons Growth Investors Will Love ATI (ATI)Zacks Investment Research•Mar 13, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | — | 4.36B | 4.17B | 3.84B | 2.80B | 2.98B | 4.12B | 4.05B | 3.53B | 3.13B |
| Cost of Revenue | — | 3.45B | 3.35B | 3.12B | 2.47B | 2.69B | 3.48B | 3.42B | 3.03B | 2.90B |
| Gross Profit | — | 913.50M | 826.30M | 714.20M | 334.00M | 292.80M | 638.00M | 630.30M | 497.00M | 234.10M |
| Research and Development Expenses | — | 22.10M | 22.10M | 17.70M | 20.00M | 14.80M | 20.20M | 24.90M | 14.70M | 16.90M |
| General and Administrative Expenses | — | 64.00M | 62.30M | 60.30M | 53.70M | 40.90M | 65.30M | 57.30M | 50.50M | 43.40M |
| Selling and Marketing Expenses | — | 304.60M | 345.50M | 98.80M | -20.60M | 204.80M | 275.50M | 244.80M | 251.80M | 266.70M |
| Selling General and Administrative Expenses | — | 368.60M | 407.80M | 159.10M | 33.10M | 245.70M | 340.80M | 302.10M | 302.30M | 310.10M |
| Other Expenses | — | -86.10M | -70.00M | 221.30M | 163.30M | 1.33B | -89.30M | -58.80M | 45.40M | 448.90M |
| Operating Expenses | — | 304.60M | 359.90M | 398.10M | 216.40M | 1.60B | 271.70M | 268.20M | 362.40M | 775.90M |
| Cost and Expenses | — | 3.75B | 3.71B | 3.52B | 2.68B | 4.28B | 3.76B | 3.68B | 3.39B | 3.68B |
| Net Interest Income | — | -108.20M | -92.80M | -87.40M | -96.90M | -94.40M | -99.00M | -101.00M | -133.80M | -124.00M |
| Interest Income | — | 16.00M | 13.00M | 4.70M | 0 | 1.70M | 5.90M | 0 | 0 | 0 |
| Interest Expense | — | 124.20M | 105.80M | 92.10M | 96.90M | 96.10M | 104.90M | 101.00M | 133.80M | 124.00M |
| Depreciation and Amortization | — | 151.50M | 146.10M | 142.90M | 143.90M | 143.30M | 151.10M | 156.40M | 160.80M | 170.30M |
| EBITDA | — | 670.70M | 539.10M | 678.50M | 492.50M | 198.40M | 448.30M | 484.60M | 339.90M | 74.60M |
| EBIT | — | 544.90M | 418.50M | 555.10M | 367.10M | 47.10M | 297.20M | 328.20M | 194.70M | -77.30M |
| Non Operating Income Excluding Interest | — | 64.00M | 47.90M | -239.00M | -249.50M | -1.35B | 69.10M | 33.90M | -60.10M | -464.50M |
| Operating Income | — | 608.90M | 466.40M | 316.10M | 117.60M | -1.30B | 366.30M | 362.10M | 134.60M | -541.80M |
| Total Other Income Expenses Net | — | -122.80M | -171.20M | 38.50M | 115.80M | -179.20M | -129.80M | -114.40M | -221.10M | -192.20M |
| Income Before Tax | — | 486.10M | 295.20M | 354.60M | 233.40M | -1.48B | 236.50M | 247.70M | -86.50M | -734.00M |
| Income Tax Expense | — | 103.40M | -128.20M | 15.50M | 26.80M | 77.70M | -28.50M | 11.00M | -6.80M | -106.90M |
| Net Income From Continuing Operations | — | 382.70M | 423.40M | 339.10M | 206.60M | -1.56B | 265.00M | 236.70M | -79.70M | -627.10M |
| Net Income From Discontinued Operations | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | — | 0 | 0 | 0 | 0 | 0 | -5.10M | 0 | 0 | 0 |
| Net Income | — | 382.70M | 423.40M | 339.10M | 206.60M | -1.56B | 265.00M | 236.70M | -79.70M | -627.10M |
| Net Income Deductions | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | — | 2.82 | 3.21 | 2.54 | 1.45 | -12.43 | 2.01 | 1.78 | -0.83 | -5.97 |
| EPS Diluted | — | 2.55 | 2.81 | 2.23 | 1.31 | -12.43 | 1.81 | 1.61 | -0.83 | -5.97 |
| Weighted Average SHS Out | — | 130.40M | 128.10M | 127.50M | 127.10M | 126.50M | 125.80M | 145.90M | 110.10M | 107.30M |
| Weighted Average SHS Out Dil | — | 146.80M | 150.00M | 151.20M | 127.10M | 126.50M | 146.50M | 145.90M | 110.10M | 107.30M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.22 | 0.21 | 0.2 | 0.19 | 0.12 | 0.1 | 0.15 | 0.16 | 0.14 | 0.07 |
| R&D to Revenue | 0 | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 | 0.01 | 0 | 0.01 |
| SG&A to Revenue | 0 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Interest Burden | 0.84 | 0.89 | 0.71 | 0.64 | 0.64 | -31.46 | 0.8 | 0.75 | -0.44 | 9.5 |
| EBIT Margin | 0.14 | 0.12 | 0.1 | 0.14 | 0.13 | 0.02 | 0.07 | 0.08 | 0.06 | -0.02 |
| EBITDA Margin | 0.17 | 0.15 | 0.13 | 0.18 | 0.18 | 0.07 | 0.11 | 0.12 | 0.1 | 0.02 |
| EBT per EBIT | 0.81 | 0.8 | 0.63 | 1.12 | 1.98 | 1.14 | 0.65 | 0.68 | -0.64 | 1.35 |
| Effective Tax Rate | 0.2 | 0.21 | -0.43 | 0.04 | 0.11 | -0.05 | -0.12 | 0.04 | 0.08 | 0.15 |
| Tax Burden | 0.77 | 0.76 | 1.39 | 0.91 | 0.79 | 1.06 | 1.07 | 0.9 | 1.06 | 0.87 |
| Cont. Operations Profit Margin | 0.09 | 0.09 | 0.1 | 0.09 | 0.07 | -0.52 | 0.06 | 0.06 | -0.02 | -0.2 |
| Bottom Line Profit Margin | 0.09 | 0.08 | 0.1 | 0.08 | 0.07 | -0.53 | 0.06 | 0.05 | -0.03 | -0.2 |
| Operating Cycle | 203.43 | 208.87 | 195.85 | 201.01 | 223.18 | 182.42 | 173.49 | 181.62 | 198.23 | 183.14 |
| Fwd PEG Ratio | 11.28 | -1.6 | 0.54 | 0.16 | -0.1 | 0 | 0.8 | -0.05 | 0.34 | -0.04 |
| Earnings Yield | 0.03 | 0.05 | 0.07 | 0.08 | 0.09 | -0.74 | 0.1 | 0.07 | -0.03 | -0.37 |
| Income Quality | 1.52 | 1.06 | 0.2 | 0.66 | 0.08 | -0.11 | 0.87 | 1.66 | -0.28 | 0.07 |